{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:32:40Z","timestamp":1792459960108,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/pat.0b013e32835d0efb","type":"journal-article","created":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T12:31:16Z","timestamp":1356957076000},"page":"116-126","source":"Crossref","is-referenced-by-count":246,"title":["Tumours associated with BAP1 mutations"],"prefix":"10.1016","volume":"45","author":[{"given":"Rajmohan","family":"Murali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e32835d0efb_bib0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bfgp\/elm007","article-title":"Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease","volume":"6","author":"Angeloni","year":"2007","journal-title":"Brief Funct Genomic Proteomic"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0015","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0020","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation ofBAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity","volume":"69","author":"Nishikawa","year":"2009","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cell.2009.04.042","article-title":"Defining the human deubiquitinating enzyme interaction landscape","volume":"138","author":"Sowa","year":"2009","journal-title":"Cell"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0045","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/MCB.01517-08","article-title":"Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1","volume":"29","author":"Misaghi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12013-011-9184-6","article-title":"An emerging model for BAP1\u2019s role in regulating cell cycle progression","volume":"60","author":"Eletr","year":"2011","journal-title":"Cell Biochem Biophys"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0055","doi-asserted-by":"crossref","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","article-title":"The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1","volume":"284","author":"Machida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molcel.2007.05.030","article-title":"E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases","volume":"27","author":"Tyagi","year":"2007","journal-title":"Mol Cell"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0065","doi-asserted-by":"crossref","first-page":"10835","DOI":"10.1073\/pnas.0704351104","article-title":"The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection","volume":"104","author":"Narayanan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0070","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/MCB.00396-10","article-title":"The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression","volume":"30","author":"Yu","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbagrm.2009.08.003","article-title":"Control of alpha-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities","volume":"1799","author":"Kristie","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0080","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4161\/cc.10.6.14907","article-title":"Polycomb group proteins in the DNA damage response: a link between radiation resistance and \u2018stem-ness\u2019","volume":"10","author":"Gieni","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.molcel.2007.07.024","article-title":"A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation","volume":"27","author":"Zhu","year":"2007","journal-title":"Mol Cell"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature02985","article-title":"Role of histone H2A ubiquitination in Polycomb silencing","volume":"431","author":"Wang","year":"2004","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.devcel.2004.10.005","article-title":"Polycomb group proteins Ring1A\/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation","volume":"7","author":"de Napoles","year":"2004","journal-title":"Dev Cell"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0105","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bbrc.2006.12.166","article-title":"Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing","volume":"353","author":"Negishi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vire","year":"2006","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0115","doi-asserted-by":"crossref","first-page":"e1000155","DOI":"10.1371\/journal.pgen.1000155","article-title":"Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island","volume":"4","author":"O\u2019Hagan","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0120","doi-asserted-by":"crossref","first-page":"24790","DOI":"10.1074\/jbc.M604175200","article-title":"Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells","volume":"281","author":"Reynolds","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.1381306","article-title":"Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes","volume":"20","author":"Greenberg","year":"2006","journal-title":"Genes Dev"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0135","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.C000881200","article-title":"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation","volume":"276","author":"Hashizume","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1999.tb09414.x","article-title":"Rauscher FJ 3rd. BAP1, a candidate tumor suppressor protein that interacts with BRCA1","volume":"886","author":"Jensen","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0145","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1093\/emboj\/cdf691","article-title":"Activation of the E3 ligase function of the BRCA1\/BARD1 complex by polyubiquitin chains","volume":"21","author":"Mallery","year":"2002","journal-title":"EMBO J"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0155","unstructured":"COSMIC: catalogue of somatic mutations in cancer. Cited 5 Sept 2012. http:\/\/cancer.sanger.ac.uk\/cosmic\/gene\/analysis?ln=BAP1"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0160","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0165","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, menin-gioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0190","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.0022-202X.2004.22530.x","article-title":"Lack of BRAF mutations in Spitz nevi","volume":"122","author":"Gill","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0195","first-page":"2415","article-title":"Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma","volume":"24","author":"Mihic-Probst","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.0303-6987.2003.00179.x","article-title":"The T1796A mutation of the BRAF gene is absent in Spitz nevi","volume":"31","author":"Palmedo","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/00313020412331283879","article-title":"Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma","volume":"36","author":"Scolyer","year":"2004","journal-title":"Pathology"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24047","article-title":"The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution","volume":"115","author":"Ludgate","year":"2009","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0046-8177(99)90193-4","article-title":"Atypical Spitz nevi\/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome","volume":"30","author":"Barnhill","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0225","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PAS.0b013e3181cf7fa0","article-title":"Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008","volume":"34","author":"Cerroni","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0235","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","article-title":"Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features","volume":"157","author":"Bastian","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0240","series-title":"Am J Surg Pathol","article-title":", Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma","author":"Long","year":"2012"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0245","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Towards an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2068","article-title":"A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes","volume":"7","author":"Carbone","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0260","first-page":"4349","article-title":"Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma","volume":"53","author":"Taguchi","year":"1993","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0265","first-page":"1365","article-title":"Frequent deletion of 3p21. 1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells","volume":"39","author":"Yoshikawa","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0270","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<228::AID-GCC4>3.0.CO;2-Z","article-title":"Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development","volume":"19","author":"van den Berg","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0280","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0285","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-10-0120","article-title":"Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma","volume":"70","author":"Duns","year":"2010","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0290","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/humu.22090","article-title":"Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development","volume":"33","author":"Duns","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.1014","article-title":"Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma","volume":"44","author":"Guo","year":"2012","journal-title":"Nat Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0300","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10689-005-2833-4","article-title":"BAP1 and breast cancer risk","volume":"4","author":"Coupier","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0305","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/jhg.2009.6","article-title":"Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer","volume":"54","author":"Guenard","year":"2009","journal-title":"J Hum Genet"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0310","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1600-0463.2012.02909.x","article-title":"Somatic mutation of a tumor suppressor gene BAP1 is rare in breast, prostate, gastric and colorectal cancers","volume":"120","author":"Je","year":"2012","journal-title":"APMIS"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0315","series-title":"Curr Protoc Hum Genet","article-title":"The Catalogue of Somatic Mutations in Cancer (COSMIC)","author":"Forbes","year":"2008"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0320","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0325","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0330","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ijc.2910570406","article-title":"Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14. 3-3p21.3 in sporadic breast-cancer development","volume":"57","author":"Buchhagen","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0335","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ijc.2910640604","article-title":"Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer","volume":"64","author":"Thiberville","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0340","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0345","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic mye-lomonocytic leukaemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0350","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0355","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0360","unstructured":"OMIM: #614327. Tumor predisposition syndrome. 12 Apr 2012 (cited 5 Sep 2012). http:\/\/omim.org\/entry\/614327"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0365","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1073\/pnas.0600069103","article-title":"Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a)","volume":"103","author":"Guney","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0370","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1158\/1078-0432.CCR-06-0788","article-title":"Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas","volume":"12","author":"Silva","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0375","doi-asserted-by":"crossref","first-page":"e17918","DOI":"10.1371\/journal.pone.0017918","article-title":"Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0380","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/leu.2010.325","article-title":"Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein","volume":"25","author":"Yong","year":"2011","journal-title":"Leukemia"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","article-title":"Polycomb repressor complex-2 is a novel target for mesothelioma therapy","volume":"18","author":"Kemp","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0390","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","article-title":"EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression","volume":"9","author":"Fan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0395","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ccd.23085","article-title":"Qualitative comparison of coronary angiograms between 4 French catheters with an advanced cardiovascular injection system and 6 French catheters with manual injection","volume":"79","author":"Gonzalez","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0400","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/jcb.23234","article-title":"BMI1 as a novel target for drug discovery in cancer","volume":"112","author":"Cao","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0405","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1038\/sj.onc.1209454","article-title":"Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0410","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4161\/cc.9.13.12147","article-title":"The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors","volume":"9","author":"Bommi","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0415","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0420","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0425","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.bjc.6604817","article-title":"A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmuno-therapy in patients with advanced melanoma","volume":"100","author":"Rocca","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0435","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1073\/pnas.1018872108","article-title":"Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen","volume":"109","author":"Mendes-Pereira","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e32835d0efb_bib0440","unstructured":"NCBI. NCBI Reference Sequence: NP_004647.1. ubiquitin carboxyl-term-inal hydrolase. BAP1 [Homo sapiens]. Cited 19 Sep 2012. http:\/\/www.ncbi.nlm.nih.gov\/protein\/4757836?report=graph"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T18:40:07Z","timestamp":1562524807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516315756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0031302516315756"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e32835d0efb","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}